Damora Therapeutics logo
Damora Therapeutics
GLTO | NASDAQ
Chart Builder DCF Calculator
$21.58
-$0.75 (-3.36%)
At close: Jun 4, 2026, 12:02 PM ET

Damora Therapeutics Income Statement

Income statement explained
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
– – – – – –
34K – – – – –
-34K – – – – –
-210.87M -22.26M -39.91M -61.21M -52.23M -33.64M
1.17M 844K 1.69M 722K 156K –
-209.79M -21.4M -38.35M -61.62M -51.75M -34.84M
-209.84M -21.44M -38.35M -61.62M -51.75M -34.84M
9.69M 10.5M 12.69M 13M 13.74M 9.01M
201.19M 10.79M 23.77M 48.21M 38.49M 24.63M
– 968K 3.45M – – –
210.87M 22.26M 39.91M 61.21M 52.23M 33.64M
– – – 417K – –
– – – – – –
210.87M 22.26M 39.91M 61.21M 52.23M 33.64M
50K 41K – – – –
1.37M 1.16M 1.06M 1.02M 1.01M 1.01M
1.37M 1.16M 1.06M 1.02M 1.01M 1.01M
-152.99 -18.53 -36.08 -61.04 -50.75 -35.66
-152.99 -18.53 -36.08 -61.04 -50.75 -35.66
-209.76M -21.11M -35.63M -60.72M -51.31M -34.65M
-209.79M -21.29M -36.46M -61.21M -51.75M -34.84M
34K 181K 830K 490K 441K 188K

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.